Chromosomal translocations resulting in BCL11A overexpression are often seen in human B-ALL tumors, and kit is a proto-oncogene and early developmental marker upregulated in many hematopoietic neoplasms. This evidence concerns the gene BCL11A and hematopoietic and lymphoid cell neoplasm.